A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Public ClinicalTrials.gov record NCT01059682. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Study identification
- NCT ID
- NCT01059682
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 936 participants
Conditions and interventions
Conditions
Interventions
- Dalcetrapib Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2009
- Primary completion
- Aug 31, 2011
- Completion
- Aug 31, 2011
- Last update posted
- Mar 23, 2020
2010 – 2011
United States locations
- U.S. sites
- 41
- U.S. states
- 22
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Los Angeles | California | 90073 | — |
| Not listed | Torrance | California | 90502 | — |
| Not listed | Boulder | Colorado | 80304 | — |
| Not listed | Greeley | Colorado | 80631 | — |
| Not listed | Littleton | Colorado | 80120 | — |
| Not listed | Hartford | Connecticut | 06115 | — |
| Not listed | Atlantis | Florida | 33462 | — |
| Not listed | Fort Lauderdale | Florida | 33308 | — |
| Not listed | Fort Lauderdale | Florida | 33316 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Miami | Florida | 33137 | — |
| Not listed | Sarasota | Florida | 34239 | — |
| Not listed | Tampa | Florida | 33609 | — |
| Not listed | Decatur | Georgia | 30033 | — |
| Not listed | Chicago | Illinois | 60637-1470 | — |
| Not listed | Elkhart | Indiana | 46514 | — |
| Not listed | Louisville | Kentucky | 40205 | — |
| Not listed | Columbia | Maryland | 21044 | — |
| Not listed | Salisbury | Maryland | 21804 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Ann Arbor | Michigan | 48109-0666 | — |
| Not listed | Kalamazoo | Michigan | 49048 | — |
| Not listed | Midland | Michigan | 48670 | — |
| Not listed | Muskegon | Michigan | 49444 | — |
| Not listed | Petoskey | Michigan | 49770 | — |
| Not listed | Duluth | Minnesota | 55805 | — |
| Not listed | Rochester | Minnesota | 55905 | — |
| Not listed | Kansas City | Missouri | 64114 | — |
| Not listed | Paramus | New Jersey | 07652 | — |
| Not listed | New York | New York | 10011 | — |
| Not listed | Rochester | New York | 14642 | — |
| Not listed | Chapel Hill | North Carolina | 27599 | — |
| Not listed | Toledo | Ohio | 43614 | — |
| Not listed | Hershey | Pennsylvania | 17033 | — |
| Not listed | Providence | Rhode Island | 02906 | — |
| Not listed | Germantown | Tennessee | 38138 | — |
| Not listed | Oak Ridge | Tennessee | 37830 | — |
| Not listed | Dallas | Texas | 75216 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Richmond | Virginia | 23249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01059682, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2020 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01059682 live on ClinicalTrials.gov.